Opposing roles of the two isoforms of ErbB3 binding protein 1 in human cancer cells

被引:22
|
作者
Ko, Hyo Rim [1 ]
Chang, Yun Sil [2 ]
Park, Won Soon [2 ]
Ahn, Jee-Yin [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol,Ctr Mol Med, Suwon, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, 81 Irwonro, Seoul 06351, South Korea
关键词
Ebp1; oncogene; tumor suppressor gene; MEDIATED TRANSCRIPTION; LONG ISOFORM; EBP1; GROWTH; PHOSPHORYLATION; PROLIFERATION; EXPRESSION; REPRESSION; DIFFERENTIATION; IDENTIFICATION;
D O I
10.1002/ijc.30165
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The different functions of the two isoforms of ErbB3 binding protein 1 (Ebp1), p48 and p42, have recently become the focus of interest as they reveal contradictory roles in cell growth promoting ability. The conformational change that crystal structure of p42 was shown to lack a helices at the amino-terminus present in p48 represents the differential binding partners and protein modifications of two Ebp1 isoforms. N-terminal specific phosphorylation by CDK2 and deregulation of the p53 tumor suppressor through specific interaction with HDM2 and Akt activation is postulated to contribute to p48-mediated tumorigenesis. The short isoform p42 Ebp1, which is actual binding partner of ErbB3 has been implicated as a tumor suppressor with many binding partners such as Rb, HDAC2, Sin3A and the p85 subunit of PI3K with HSP70/CHIP, inhibiting its own antiproliferative activity or inhibiting PI3K activity. The aim of the current review is to provide a summary on distinctive cellular functions of two Ebp1 proteins and their molecular partners that might be responsible for the unique functions of each isoform of Ebp1.
引用
收藏
页码:1202 / 1208
页数:7
相关论文
共 50 条
  • [31] The Regulation of Nuclear ErbB3 by the Androgen Receptor in Prostate Cancer Cells
    Jathal, Maitreyee
    Siddiqui, Salma
    Johnson, Blythe
    Ghosh, Paramita
    FASEB JOURNAL, 2021, 35
  • [32] ErbB3 is required for erbB2-mediated paclitaxel resistance in breast cancer cells
    Wang, Shuiliang
    Gao, Lizhi
    Huang, Xiaoping
    Liu, Bolin
    CANCER RESEARCH, 2009, 69
  • [33] The Role of ERBB2/ERBB3 Signal Pathway in Generation of Cancer Stem Cells
    Hassan, Ghmkin
    Seno, Masaharu
    CANCER SCIENCE, 2021, 112 : 281 - 281
  • [34] Mechanisms of Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3) Action in Human Neoplasia
    Black, Laurel E.
    Longo, Jody F.
    Carroll, Steven L.
    AMERICAN JOURNAL OF PATHOLOGY, 2019, 189 (10): : 1898 - 1912
  • [35] Quercetin decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human colon cancer cells
    Kim, WK
    Bang, MH
    Kim, ES
    Kang, NE
    Jung, KC
    Cho, HJ
    Park, JHY
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2005, 16 (03): : 155 - 162
  • [36] Inhibition of heregulin mediated MCF-7 breast cancer cell growth by the ErbB3 binding protein EBP1
    Zhang, Yuexing
    Akinmade, Damilola
    Hamburger, Anne W.
    CANCER LETTERS, 2008, 265 (02) : 298 - 306
  • [37] MBNL1 alternative splicing isoforms play opposing roles in cancer
    Tabaglio, Tommaso
    Low, Diana H. P.
    Teo, Winnie Koon Lay
    Goy, Pierre Alexis
    Cywoniuk, Piotr
    Wollmann, Heike
    Ho, Jessica
    Tan, Damien
    Aw, Joey
    Pavesi, Andrea
    Sobczak, Krzysztof
    Wee, Dave Keng Boon
    Guccione, Ernesto
    LIFE SCIENCE ALLIANCE, 2018, 1 (05)
  • [38] Alterations in cell growth and signaling in ErbB3 binding protein-1 (Ebp1) deficient mice
    Zhang, Yuexing
    Lu, Yan
    Zhou, Hua
    Lee, Myounghee
    Liu, Zhenqiu
    Hassel, Bret A.
    Hamburger, Anne W.
    BMC CELL BIOLOGY, 2008, 9 (1)
  • [39] Alterations in cell growth and signaling in ErbB3 binding protein-1 (Ebp1) deficient mice
    Yuexing Zhang
    Yan Lu
    Hua Zhou
    Myounghee Lee
    Zhenqiu Liu
    Bret A Hassel
    Anne W Hamburger
    BMC Cell Biology, 9
  • [40] Roles and mechanisms of NRG1 in modulating the pathogenesis of NAFLD through ErbB3 signaling in hepatocytes (NRG1 modulates NAFLD through ErbB3 signaling)
    Meng, Di
    Pan, Hongying
    Chen, Youwei
    Ding, Jiexia
    Dai, Yining
    OBESITY RESEARCH & CLINICAL PRACTICE, 2021, 15 (02) : 145 - 151